Carmell Therapeutics Corp:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Carmell Therapeutics Corp - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7029
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Carmell Therapeutics Corp (Carmell) is a biotechnology company that develops and commercializes bone healing accelerants and tissue healing accelerants. Its pipeline portfolio include adjunctive treatment for long bone fractures in Phase I and Phase II a; and adjunctive treatment for total joint replacement; enhancer and extender for demineralized bone spine; and tissue healing accelerants to reduce surgical site infections in colorectal surgery, sternotomy, cesarean section, and hysterectomy in preclinical phase. Carmell’s pipeline products are based on its patented plasma-based bioactive materials (PBMs). The company caters its products to surgical site infection and orthopedic markets. Carmell is headquartered in Pittsburgh, Pennsylvania, the US.

Carmell Therapeutics Corp – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Carmell Therapeutics Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Carmell Therapeutics Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Carmell Therapeutics Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Carmell Therapeutics Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Carmell Therapeutics Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Carmell Therapeutics Corp, Medical Equipment, Deal Details 10
Venture Financing 10
Carmell Therapeutics Raises USD0.4 Million in Financing 10
Carmell Therapeutics Raises USD4 Million in Series B Financing 11
Carmell Therapeutics Raises USD0.8 Million in Financing Round 12
Carmell Therapeutics Secures Venture Funding from Innovation Works 13
Carmell Therapeutics Raises USD0.1 Million in Venture Financing 14
Carmell Therapeutics Secures USD0.3 Million in Venture Funding from Innovation Works 15
Carmell Therapeutics Raises US$0.4 Million In Venture Financing 16
Carmell Therapeutics Raises USD0.4 Million In Venture Financing 17
Carmell Therapeutics Corp – Key Competitors 18
Carmell Therapeutics Corp – Key Employees 19
Carmell Therapeutics Corp – Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Product News 21
Jun 22, 2017: Carmell Therapeutics announced the issuance of Canadian Patent No. 2701187 for METHODS AND APPARATUS FOR MANUFACTURING PLASMA BASED PLASTICS 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Carmell Therapeutics Corp, Medical Equipment, Key Facts 2
Carmell Therapeutics Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Carmell Therapeutics Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Carmell Therapeutics Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Carmell Therapeutics Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Carmell Therapeutics Corp, Deals By Market, 2012 to YTD 2018 8
Carmell Therapeutics Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Carmell Therapeutics Raises USD0.4 Million in Financing 10
Carmell Therapeutics Raises USD4 Million in Series B Financing 11
Carmell Therapeutics Raises USD0.8 Million in Financing Round 12
Carmell Therapeutics Secures Venture Funding from Innovation Works 13
Carmell Therapeutics Raises USD0.1 Million in Venture Financing 14
Carmell Therapeutics Secures USD0.3 Million in Venture Funding from Innovation Works 15
Carmell Therapeutics Raises US$0.4 Million In Venture Financing 16
Carmell Therapeutics Raises USD0.4 Million In Venture Financing 17
Carmell Therapeutics Corp, Key Competitors 18
Carmell Therapeutics Corp, Key Employees 19

List of Figures
Carmell Therapeutics Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Carmell Therapeutics Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Carmell Therapeutics Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Carmell Therapeutics Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Carmell Therapeutics Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Carmell Therapeutics Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Carmell Therapeutics Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Carmell Therapeutics Corp:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Aegion Corp (AEGN):企業の財務・戦略的SWOT分析
    Aegion Corp (AEGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • NovoCure Ltd (NVCR)-製薬・医療分野:企業M&A・提携分析
    Summary NovoCure Ltd (NovoCure) is an drug company that concentrates on the development and commercialization of novel therapies for tumor treating fields. The company’s pipeline products find application in various types of cancer indications such as ovarian cancer, malignant melanoma, hepatocellul …
  • Air India Ltd.:企業の戦略・SWOT・財務分析
    Air India Ltd. - Strategy, SWOT and Corporate Finance Report Summary Air India Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Selvita SA (SLV):企業の財務・戦略的SWOT分析
    Summary Selvita SA (Selvita) is a drug discovery company that focuses on the research and development of cancer therapies. The company develops novel small molecule drugs, and markets them with partners from the pharmaceutical industry. Its products find application in the therapeutic areas of oncol …
  • China Metallurgical Group Corp (1618):企業の財務・戦略的SWOT分析
    China Metallurgical Group Corp (1618) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • G. Pohl-Boskamp GmbH & Co KG:製薬・医療:M&Aディール及び事業提携情報
    Summary G. Pohl-Boskamp GmbH & Co KG (Pohl-Boskamp) is a developer of medicines and medical devices. The company offers products which include GeloMyrtol forte, GeloRevoice, GeloSitin Nasenpflege, GeloSitin Nasal Care, GeloBronchial-Saft, GeloDurat-Salbe, GeloDuratInhalator N, Laxopol, Nitrolingual …
  • 23andMe Inc:医療機器:M&Aディール及び事業提携情報
    Summary 23andMe Inc (23andMe) is a biotechnology research and information provider that offers tools for health and ancestry care. The company offers raw genetic data and ancestry-related genetic reports. Its service portfolio includes clinical development, research and development, ancestry service …
  • Agilent Technologies, Inc.:戦略・SWOT・企業財務分析
    Agilent Technologies, Inc. - Strategy, SWOT and Corporate Finance Report Summary Agilent Technologies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Honkarakenne Oyj (HONBS):企業の財務・戦略的SWOT分析
    Honkarakenne Oyj (HONBS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • GUD Holdings Ltd (GUD):企業の財務・戦略的SWOT分析
    GUD Holdings Ltd (GUD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Dalet S.A. (DLT):企業の財務・戦略的SWOT分析
    Dalet S.A. (DLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Cognition Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Cognition Therapeutics Inc (CogRx) is a drug discovery and development company that discovers and develops small molecule therapeutics to improve the lives of individuals with Alzheimer’s disease and other neurocognitive disorders. The company uses its proprietary biology and chemistry platf …
  • Dell Technologies Inc (DVMT):医療機器:M&Aディール及び事業提携情報
    Summary Dell Technologies, Inc. (Dell), is a provider of desktop personal computers, software and peripherals. The company designs, develops, manufactures, markets, sells and supports information technology infrastructure such as laptops, desktops, mobiles, workstations, storage devices and printers …
  • Fluidigm Corp (FLDM):医療機器:M&Aディール及び事業提携情報
    Summary Fluidigm Corp (Fluidigm), formerly Mycometrix Corp, develops, manufactures, and markets life science analytical and preparatory systems for mass cytometry, high-throughput genomics, and single-cell genomics markets. The company offers analytical systems and instruments, preparatory instrumen …
  • Esco Technologies Inc (ESE):企業の財務・戦略的SWOT分析
    Esco Technologies Inc (ESE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Evotec AG (EVT):医療機器:M&Aディール及び事業提携情報
    Summary Evotec AG (Evotec) is a drug discovery alliance and development partnership company. It identifies and develops small molecule drugs across various therapeutic areas such as, cancer, neurological and nephrological conditions, cardiovascular, inflammation, pain, metabolic and respiratory dise …
  • Metsa Group:企業の戦略・SWOT・財務情報
    Metsa Group - Strategy, SWOT and Corporate Finance Report Summary Metsa Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • SpareBank 1 Nord-Norge:企業の戦略・SWOT・財務分析
    SpareBank 1 Nord-Norge - Strategy, SWOT and Corporate Finance Report Summary SpareBank 1 Nord-Norge - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • The Kansai Electric Power Company Inc (9503)-エネルギー分野:企業M&A・提携分析
    Summary The Kansai Electric Power Company Inc (KEPCo) is an integrated power utility. The company produces and supplies electricity; and procures and sells natural gas. It generates electricity from natural gas, oil, nuclear, coal, hydro, wind, and solar sources. Through long, medium, and short term …
  • Mitsui E&S Holdings Co., Ltd. (7003):企業の財務・戦略的SWOT分析
    Mitsui E&S Holdings Co., Ltd. (7003) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆